| 产品详情 |
| Edit |   |
|---|
| Product Name | (R)-CR8 |
|---|
| Description | A second-generation analog of (R)-roscovitine that inhibits Cdk1, 2, 5, and 9 (IC50s = 0.09, 0.072-0.041, 0.11, and 0.18 µM, respectively) with improved potency over its parent compound; also inhibits CK1δ/ε (IC50 = 0.40 µM) and GSK-3α/β (IC50 = 12 µM) |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | cyclin-dependent kinases CDK cells cycles cancers (R)-roscovitine Cdk1/cyclin B Cdk2/cyclin A Cdk2/cyclin E Cdk5/p25 Cdk9/cyclin T inhibitors casein kinase1 CK1δ/ε, GSK-3α/β inhibits inhibitions apoptosis glycogen induce synthase inducer CR8 CR-8 |
|---|
| Gene, Accession, CAS # | CAS: 294646-77-8 |
|---|
| Catalog # | 14006-50 |
|---|
| Price | |
|---|
| Order / More Info | (R)-CR8 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|